215 related articles for article (PubMed ID: 3045820)
1. Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.
Seelmeier S; Schmidt H; Turk V; von der Helm K
Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6612-6. PubMed ID: 3045820
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A.
von der Helm K; Gürtler L; Eberle J; Deinhardt F
FEBS Lett; 1989 Apr; 247(2):349-52. PubMed ID: 2469601
[TBL] [Abstract][Full Text] [Related]
3. Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin.
Parikh S; Liu J; Sijwali P; Gut J; Goldberg DE; Rosenthal PJ
Antimicrob Agents Chemother; 2006 Jun; 50(6):2207-9. PubMed ID: 16723585
[TBL] [Abstract][Full Text] [Related]
4. Biological activity of aspartic proteinase inhibitors related to pepstatin.
Gunn JM; Owens RA; Liu WS; Glover GI
Acta Biol Med Ger; 1981; 40(10-11):1547-53. PubMed ID: 6805191
[TBL] [Abstract][Full Text] [Related]
5. Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analogue inhibitor.
Rich DH
J Med Chem; 1985 Mar; 28(3):263-73. PubMed ID: 3882966
[No Abstract] [Full Text] [Related]
6. Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases.
Richards AD; Roberts R; Dunn BM; Graves MC; Kay J
FEBS Lett; 1989 Apr; 247(1):113-7. PubMed ID: 2651157
[TBL] [Abstract][Full Text] [Related]
7. Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody.
Hansen J; Billich S; Schulze T; Sukrow S; Moelling K
EMBO J; 1988 Jun; 7(6):1785-91. PubMed ID: 3049075
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease.
Meek TD; Dayton BD; Metcalf BW; Dreyer GB; Strickler JE; Gorniak JG; Rosenberg M; Moore ML; Magaard VW; Debouck C
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1841-5. PubMed ID: 2648384
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease.
Schneider J; Kent SB
Cell; 1988 Jul; 54(3):363-8. PubMed ID: 3293801
[TBL] [Abstract][Full Text] [Related]
10. The proteinase inhibitor pepstatin A inhibits formation of reverse transcriptase in H9 cells infected with human immunodeficiency virus 1.
Grinde B; Hungnes O; Tjøtta E
AIDS Res Hum Retroviruses; 1989 Jun; 5(3):269-74. PubMed ID: 2471542
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte protease activities in myotonic dystrophy: studies on effects of protease inhibitors.
Goto I; Shinno N; Kuroiwa Y
Eur Neurol; 1987; 26(2):126-8. PubMed ID: 3549315
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition.
Rich DH; Bernatowicz MS; Agarwal NS; Kawai M; Salituro FG; Schmidt PG
Biochemistry; 1985 Jun; 24(13):3165-73. PubMed ID: 3927973
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor.
Katoh I; Yasunaga T; Ikawa Y; Yoshinaka Y
Nature; 1987 Oct 15-21; 329(6140):654-6. PubMed ID: 2821409
[TBL] [Abstract][Full Text] [Related]
14. Purification and properties of a pepstatin-insensitive carboxyl proteinase from a gram-negative bacterium.
Oda K; Sugitani M; Fukuhara K; Murao S
Biochim Biophys Acta; 1987 Mar; 923(3):463-9. PubMed ID: 3548827
[TBL] [Abstract][Full Text] [Related]
15. Lower homologues of ahpatinin, aspartic protease inhibitors, from a marine Streptomyces sp.
Sun Y; Takada K; Nogi Y; Okada S; Matsunaga S
J Nat Prod; 2014 Jul; 77(7):1749-52. PubMed ID: 24960234
[TBL] [Abstract][Full Text] [Related]
16. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.
Erickson-Viitanen S; Manfredi J; Viitanen P; Tribe DE; Tritch R; Hutchison CA; Loeb DD; Swanstrom R
AIDS Res Hum Retroviruses; 1989 Dec; 5(6):577-91. PubMed ID: 2692658
[TBL] [Abstract][Full Text] [Related]
17. Pepstatin inhibition of rat myocardial acid protease.
Hokins BE; Smith TW
Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():439-43. PubMed ID: 1031998
[TBL] [Abstract][Full Text] [Related]
18. A structural model for the retroviral proteases.
Pearl LH; Taylor WR
Nature; 1987 Sep 24-30; 329(6137):351-4. PubMed ID: 3306411
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
Meek TD; Lambert DM; Dreyer GB; Carr TJ; Tomaszek TA; Moore ML; Strickler JE; Debouck C; Hyland LJ; Matthews TJ
Nature; 1990 Jan; 343(6253):90-2. PubMed ID: 1688646
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cysteine proteinase activity by Z-Phe-Phe-diazomethane and of aspartic proteinase activity by pepstatin in different organs from some animals and isolated cells from rat liver.
Riemann S; Kirschke H; Wiederanders B; Brouwer A; Shaw E; Bohley P
Acta Biol Med Ger; 1982; 41(1):83-8. PubMed ID: 7051705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
